Ignite Creation Date:
2025-12-24 @ 5:40 PM
Ignite Modification Date:
2026-01-01 @ 11:16 AM
Study NCT ID:
NCT04654468
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-11-17
First Post:
2020-11-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Not Previously Treated With Complement Inhibition
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-03-17
Start Date Type:
ACTUAL
Primary Completion Date:
2022-02-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2020-11-30
First Submit QC Date:
None
Study First Post Date:
2020-12-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-02-06
Results First Submit QC Date:
None
Results First Post Date:
2023-06-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-11
Last Update Post Date:
2025-11-17
Last Update Post Date Type:
ESTIMATED